GENESIS informs prospective parents about our Hospital’s cutting-edge Newborn Screening program. The clinical examination of newborns’ hips, hearing, and vision during the first years of our Hospital’s operation marked the beginning of Newborn Screening. Later, we added early laboratory screening for more than 45 metabolic diseases, including Cystic Fibrosis.
The aim of the of said screening is to identify any congenital disorders (birth defects) early on, as their symptoms do not typically occur when a baby is young but can later result in serious issues. Early detection allows for immediate management and treatment initiation, reducing the risk of potentially harmful complications. Despite being present in very small percentages, congenital disorders identified through our screening programs are not treated as insignificant, considering the level of healthcare services that GENESIS aims to provide.
This program is carried out by specialized medical personnel and laboratories, under the scientific direction of the Hospital’s Department of Neonatology and in accordance with current international scientific guidelines and advances.